Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HOXB and HOXD genes contribute to the carcinogenic processes in glioblastoma: evidence form a bioinformatics analysis. | Cancer Treat Res Commun | 2025 | 40209540 | PubTator, text mining | PubMed |
| The AhR pathway is dysregulated in alopecia areata. | J Transl Autoimmun | 2025 | 40162433 | PubTator, text mining | PubMed |
| Investigation of immune checkpoint molecules (CTLA-4, PD-1, PD-L1, Tim-3) expressions in preeclampsia: A comparative study of membranous and soluble forms. | Hum Immunol | 2025 | 40154098 | PubTator, text mining | PubMed |
| Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. | Pharmaceuticals (Basel) | 2025 | 40143207 | PubTator, text mining | PubMed |
| Soft Pneumatic Device Designed to Mimic the Periosteal Environment for Regulating the Fate of Mesenchymal Stem Cells. | Adv Healthc Mater | 2025 | 40123288 | PubTator, text mining | PubMed |
| A blood-based liquid biopsy analyzing soluble immune checkpoints and cytokines identifies distinct neuroendocrine tumors. | J Exp Clin Cancer Res | 2025 | 40038821 | PubTator, text mining | PubMed |
| Finding the best column for polar basic analytes across reversed-phase and hydrophilic interaction liquid chromatography. | Heliyon | 2025 | 40028593 | PubTator, text mining | PubMed |
| High serum levels of soluble PD‑1 and PD‑L1 are associated with advanced clinical stages in patients with cervical cancer. | Biomed Rep | 2025 | 40017501 | PubTator, text mining | PubMed |
| Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity. | Medicina (Kaunas) | 2025 | 40005306 | PubTator, text mining | PubMed |
| Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications. | Biomedicines | 2025 | 40002913 | PubTator, text mining | PubMed |
| Liquid-Based Diagnostic Panels for Prostate Cancer: The Synergistic Role of Soluble PD-L1, PD-1, and mRNA Biomarkers. | Int J Mol Sci | 2025 | 39859417 | PubTator, text mining | PubMed |
| Evaluating the Diagnostic Value of Lymphocyte Subsets in Bronchoalveolar Lavage Fluid and Peripheral Blood Across Various Diffuse Interstitial Lung Disease Subtypes. | Biomolecules | 2025 | 39858516 | PubTator, text mining | PubMed |
| [Clinical sub-phenotypes of acute kidney injury in children and their association with prognosis]. | Zhongguo Dang Dai Er Ke Za Zhi | 2025 | 39825651 | PubTator, text mining | PubMed |
| Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma. | Sci Rep | 2025 | 39805878 | PubTator, text mining | PubMed |
| Knockdown of HOXD13 in Oral Squamous Cell Carcinoma Inhibited its Proliferation, Migration, and Influenced Fatty Acid Metabolism. | J Cancer | 2025 | 39744569 | PubTator, text mining | PubMed |
| Novel function of Hox13 in regulating outgrowth of the newt hindlimb bud through interaction with Fgf10 and Tbx4. | Dev Growth Differ | 2025 | 39725403 | PubTator, text mining | PubMed |
| Human colon organoid differentiation from induced pluripotent stem cells using an improved method. | FEBS Lett | 2025 | 39716027 | PubTator, text mining | PubMed |
| The induction of polyamines metabolism pathway and membrane stability with silicon alleviate the vanadium toxicity in pepper plants. | J Hazard Mater | 2025 | 39647327 | PubTator, text mining | PubMed |
| Unraveling the Genetic Basis of Congenital Limb Anomalies in Eight Families. | Clin Genet | 2025 | 39639541 | PubTator, text mining | PubMed |
| Maternal supplementation spermidine during gestation improves placental angiogenesis and reproductive performance of high prolific sows. | J Nutr Biochem | 2025 | 39491598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=5